Is TSH suppression still necessary in intermediate- and high-risk papillary thyroid cancer patients with pre-ablation stimulated thyroglobulin <1 ng/mL before ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-03-28

AUTHORS

Tian Tian, Rui Huang, Bin Liu

ABSTRACT

OBJECTIVE: Since papillary thyroid cancer (PTC) patients with pre-ablation stimulated thyroglobulin (s-Tg) < 1 ng/mL generally have a favorable prognosis, is TSH suppression still necessary in intermediate- and high-risk PTC patients with pre-ablation s-Tg < 1 ng/mL after initial therapy? The aim of this study was to assess the rate of disease recurrence in intermediate- and high-risk PTC patients with pre-ablation s-Tg < 1 ng/mL according to TSH levels measured 1 year after initial therapy. METHODS: A retrospective series of intermediate- and high-risk PTC patients with pre-ablation s-Tg < 1 ng/mL was analyzed. Disease status was defined as the presence or absence of structural disease during late follow-up. Patients were grouped according to TSH level at 1 year: group 1, TSH < 0.1 mIU/L; group 2, TSH 0.1‒0.5 mIU/L; group 3, 0.5‒2 mIU/L; group 4, >2 mIU/L. RESULTS: This study included 166 patients (78.3% females, median age 44 years) of whom the risk of recurrence was intermediate in 97 (58.4%) and high in 69 (41.6%). The response to initial therapy at 1 year was excellent in 163 patients (98.2%) and indeterminate in 3 (1.8%). Group 1 consisted of 63 patients (38%), group 2 of 47 (28%), group 3 of 28 (17%), and group 4 of 28 (17%). During a median follow-up duration of 5.8 years, disease recurrence was observed in only 4 patients (2.4%). The rate of disease recurrence was not significantly different between the TSH groups. CONCLUSION: TSH suppression before the first response to treatment assessment does not seem to influence the rate of disease recurrence after initial therapy in intermediate- and high-risk PTC patients with pre-ablation s-Tg < 1 ng/mL. More... »

PAGES

1-6

References to SciGraph publications

Journal

TITLE

Endocrine

ISSUE

N/A

VOLUME

N/A

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12020-019-01914-z

DOI

http://dx.doi.org/10.1007/s12020-019-01914-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1113061473

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30924085


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Nuclear Medicine, West China Hospital, Sichuan University, 610041, Chengdu, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tian", 
        "givenName": "Tian", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Nuclear Medicine, West China Hospital, Sichuan University, 610041, Chengdu, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huang", 
        "givenName": "Rui", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Nuclear Medicine, West China Hospital, Sichuan University, 610041, Chengdu, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "Bin", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1530/erc-15-0458", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000331339"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1530/erc-15-0458", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000331339"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/thy.2015.0020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007626247"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2016-2860", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011324995"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/cen.13158", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011770780"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/cen.13158", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011770780"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bone.2014.10.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015212969"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/cen.12668", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041357370"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/cen.12668", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041357370"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/cen.13024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048581432"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/cen.13024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048581432"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12020-015-0575-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051714652", 
          "https://doi.org/10.1007/s12020-015-0575-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12020-015-0575-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051714652", 
          "https://doi.org/10.1007/s12020-015-0575-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/thy.1998.8.737", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059318894"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/thy.2014.0287", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059321919"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2010-0161", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064292019"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2012-1533", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064293516"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2012-3401", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064293913"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2013-3156", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064294609"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jamasurg.2017.0461", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084514665"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/thy.2017.0177", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090618504"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1530/erc-17-0453", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1093087164"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1530/erc-17-0453", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1093087164"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1530/erc-17-0453", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1093087164"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/thy.2017.0352", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103522639"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/pcmedi/pby001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103721372"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s2213-8587(18)30113-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104252312"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s2213-8587(18)30113-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104252312"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s2213-8587(18)30113-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104252312"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/thy.2018.0186", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104548846"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/thy.2018.0186", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104548846"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/thy.2018.0186", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104548846"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1515/jpem-2018-0075", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1105227079"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41574-018-0068-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1105943493", 
          "https://doi.org/10.1038/s41574-018-0068-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s2213-8587(18)30306-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110228168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s2213-8587(18)30306-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110228168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s2213-8587(18)30306-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110228168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s2213-8587(18)30306-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110228168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ecl.2018.10.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110367878"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ecl.2018.10.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110367878"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ecl.2018.10.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110367878"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2018-02680", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1112259219"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-03-28", 
    "datePublishedReg": "2019-03-28", 
    "description": "OBJECTIVE: Since papillary thyroid cancer (PTC) patients with pre-ablation stimulated thyroglobulin (s-Tg)\u2009<\u20091\u2009ng/mL generally have a favorable prognosis, is TSH suppression still necessary in intermediate- and high-risk PTC patients with pre-ablation s-Tg\u2009<\u20091\u2009ng/mL after initial therapy? The aim of this study was to assess the rate of disease recurrence in intermediate- and high-risk PTC patients with pre-ablation s-Tg\u2009<\u20091\u2009ng/mL according to TSH levels measured 1 year after initial therapy.\nMETHODS: A retrospective series of intermediate- and high-risk PTC patients with pre-ablation s-Tg\u2009<\u20091\u2009ng/mL was analyzed. Disease status was defined as the presence or absence of structural disease during late follow-up. Patients were grouped according to TSH level at 1 year: group 1, TSH\u2009<\u20090.1\u2009mIU/L; group 2, TSH 0.1\u20120.5\u2009mIU/L; group 3, 0.5\u20122\u2009mIU/L; group 4, >2\u2009mIU/L.\nRESULTS: This study included 166 patients (78.3% females, median age 44 years) of whom the risk of recurrence was intermediate in 97 (58.4%) and high in 69 (41.6%). The response to initial therapy at 1 year was excellent in 163 patients (98.2%) and indeterminate in 3 (1.8%). Group 1 consisted of 63 patients (38%), group 2 of 47 (28%), group 3 of 28 (17%), and group 4 of 28 (17%). During a median follow-up duration of 5.8 years, disease recurrence was observed in only 4 patients (2.4%). The rate of disease recurrence was not significantly different between the TSH groups.\nCONCLUSION: TSH suppression before the first response to treatment assessment does not seem to influence the rate of disease recurrence after initial therapy in intermediate- and high-risk PTC patients with pre-ablation s-Tg\u2009<\u20091\u2009ng/mL.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s12020-019-01914-z", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1112251", 
        "issn": [
          "1355-008X", 
          "1559-0100"
        ], 
        "name": "Endocrine", 
        "type": "Periodical"
      }
    ], 
    "name": "Is TSH suppression still necessary in intermediate- and high-risk papillary thyroid cancer patients with pre-ablation stimulated thyroglobulin <1 ng/mL before the first disease assessment?", 
    "pagination": "1-6", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "f79c8e840be6b03e384b3579c4a2bb10d56be0f4ad292bc7e6cd3c82406a7d22"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30924085"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9434444"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12020-019-01914-z"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1113061473"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12020-019-01914-z", 
      "https://app.dimensions.ai/details/publication/pub.1113061473"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000368_0000000368/records_78953_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs12020-019-01914-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12020-019-01914-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12020-019-01914-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12020-019-01914-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12020-019-01914-z'


 

This table displays all metadata directly associated to this object as RDF triples.

157 TRIPLES      21 PREDICATES      52 URIs      18 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12020-019-01914-z schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N6439ca1f5f0f4b808c9e651c16618a8a
4 schema:citation sg:pub.10.1007/s12020-015-0575-0
5 sg:pub.10.1038/s41574-018-0068-3
6 https://doi.org/10.1001/jamasurg.2017.0461
7 https://doi.org/10.1016/j.bone.2014.10.009
8 https://doi.org/10.1016/j.ecl.2018.10.008
9 https://doi.org/10.1016/s2213-8587(18)30113-x
10 https://doi.org/10.1016/s2213-8587(18)30306-1
11 https://doi.org/10.1089/thy.1998.8.737
12 https://doi.org/10.1089/thy.2014.0287
13 https://doi.org/10.1089/thy.2015.0020
14 https://doi.org/10.1089/thy.2017.0177
15 https://doi.org/10.1089/thy.2017.0352
16 https://doi.org/10.1089/thy.2018.0186
17 https://doi.org/10.1093/pcmedi/pby001
18 https://doi.org/10.1111/cen.12668
19 https://doi.org/10.1111/cen.13024
20 https://doi.org/10.1111/cen.13158
21 https://doi.org/10.1210/jc.2010-0161
22 https://doi.org/10.1210/jc.2012-1533
23 https://doi.org/10.1210/jc.2012-3401
24 https://doi.org/10.1210/jc.2013-3156
25 https://doi.org/10.1210/jc.2016-2860
26 https://doi.org/10.1210/jc.2018-02680
27 https://doi.org/10.1515/jpem-2018-0075
28 https://doi.org/10.1530/erc-15-0458
29 https://doi.org/10.1530/erc-17-0453
30 schema:datePublished 2019-03-28
31 schema:datePublishedReg 2019-03-28
32 schema:description OBJECTIVE: Since papillary thyroid cancer (PTC) patients with pre-ablation stimulated thyroglobulin (s-Tg) < 1 ng/mL generally have a favorable prognosis, is TSH suppression still necessary in intermediate- and high-risk PTC patients with pre-ablation s-Tg < 1 ng/mL after initial therapy? The aim of this study was to assess the rate of disease recurrence in intermediate- and high-risk PTC patients with pre-ablation s-Tg < 1 ng/mL according to TSH levels measured 1 year after initial therapy. METHODS: A retrospective series of intermediate- and high-risk PTC patients with pre-ablation s-Tg < 1 ng/mL was analyzed. Disease status was defined as the presence or absence of structural disease during late follow-up. Patients were grouped according to TSH level at 1 year: group 1, TSH < 0.1 mIU/L; group 2, TSH 0.1‒0.5 mIU/L; group 3, 0.5‒2 mIU/L; group 4, >2 mIU/L. RESULTS: This study included 166 patients (78.3% females, median age 44 years) of whom the risk of recurrence was intermediate in 97 (58.4%) and high in 69 (41.6%). The response to initial therapy at 1 year was excellent in 163 patients (98.2%) and indeterminate in 3 (1.8%). Group 1 consisted of 63 patients (38%), group 2 of 47 (28%), group 3 of 28 (17%), and group 4 of 28 (17%). During a median follow-up duration of 5.8 years, disease recurrence was observed in only 4 patients (2.4%). The rate of disease recurrence was not significantly different between the TSH groups. CONCLUSION: TSH suppression before the first response to treatment assessment does not seem to influence the rate of disease recurrence after initial therapy in intermediate- and high-risk PTC patients with pre-ablation s-Tg < 1 ng/mL.
33 schema:genre research_article
34 schema:inLanguage en
35 schema:isAccessibleForFree false
36 schema:isPartOf sg:journal.1112251
37 schema:name Is TSH suppression still necessary in intermediate- and high-risk papillary thyroid cancer patients with pre-ablation stimulated thyroglobulin <1 ng/mL before the first disease assessment?
38 schema:pagination 1-6
39 schema:productId N31113aa674314339a8b8d2ec47370c45
40 N521db38a0ec94f668ae09914052b440d
41 Na78996ac16fe47d39a28f1f02948c9fd
42 Ncc0d6b468446472fb033c00849e31dbe
43 Ne0aa10d98f474e11be46900dfc81867e
44 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113061473
45 https://doi.org/10.1007/s12020-019-01914-z
46 schema:sdDatePublished 2019-04-11T13:19
47 schema:sdLicense https://scigraph.springernature.com/explorer/license/
48 schema:sdPublisher Nf52ef89d0b6c4d7cba4ff2a52b58880e
49 schema:url https://link.springer.com/10.1007%2Fs12020-019-01914-z
50 sgo:license sg:explorer/license/
51 sgo:sdDataset articles
52 rdf:type schema:ScholarlyArticle
53 N31113aa674314339a8b8d2ec47370c45 schema:name nlm_unique_id
54 schema:value 9434444
55 rdf:type schema:PropertyValue
56 N34aab735a05b453795695990fa7dcdf0 schema:affiliation Nb16fd3c00d974b90914f07bb3c7fbc69
57 schema:familyName Tian
58 schema:givenName Tian
59 rdf:type schema:Person
60 N521db38a0ec94f668ae09914052b440d schema:name doi
61 schema:value 10.1007/s12020-019-01914-z
62 rdf:type schema:PropertyValue
63 N6439ca1f5f0f4b808c9e651c16618a8a rdf:first N34aab735a05b453795695990fa7dcdf0
64 rdf:rest Nba2bb1f3716043e5971825cc0f55a3ca
65 N7d4b1657b8db48279b3bd6b6df9f3700 schema:name Department of Nuclear Medicine, West China Hospital, Sichuan University, 610041, Chengdu, China
66 rdf:type schema:Organization
67 N8aaf6134838b4456b9697fc305b74018 schema:affiliation Nd377416abc5b4e3f9608776c2973d8d6
68 schema:familyName Liu
69 schema:givenName Bin
70 rdf:type schema:Person
71 N91c553cc87754fabaeb273b2487119cf schema:affiliation N7d4b1657b8db48279b3bd6b6df9f3700
72 schema:familyName Huang
73 schema:givenName Rui
74 rdf:type schema:Person
75 Na78996ac16fe47d39a28f1f02948c9fd schema:name readcube_id
76 schema:value f79c8e840be6b03e384b3579c4a2bb10d56be0f4ad292bc7e6cd3c82406a7d22
77 rdf:type schema:PropertyValue
78 Nb16fd3c00d974b90914f07bb3c7fbc69 schema:name Department of Nuclear Medicine, West China Hospital, Sichuan University, 610041, Chengdu, China
79 rdf:type schema:Organization
80 Nba2bb1f3716043e5971825cc0f55a3ca rdf:first N91c553cc87754fabaeb273b2487119cf
81 rdf:rest Nde09a6279e2e4469a2f5449764307adb
82 Ncc0d6b468446472fb033c00849e31dbe schema:name pubmed_id
83 schema:value 30924085
84 rdf:type schema:PropertyValue
85 Nd377416abc5b4e3f9608776c2973d8d6 schema:name Department of Nuclear Medicine, West China Hospital, Sichuan University, 610041, Chengdu, China
86 rdf:type schema:Organization
87 Nde09a6279e2e4469a2f5449764307adb rdf:first N8aaf6134838b4456b9697fc305b74018
88 rdf:rest rdf:nil
89 Ne0aa10d98f474e11be46900dfc81867e schema:name dimensions_id
90 schema:value pub.1113061473
91 rdf:type schema:PropertyValue
92 Nf52ef89d0b6c4d7cba4ff2a52b58880e schema:name Springer Nature - SN SciGraph project
93 rdf:type schema:Organization
94 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
95 schema:name Medical and Health Sciences
96 rdf:type schema:DefinedTerm
97 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
98 schema:name Clinical Sciences
99 rdf:type schema:DefinedTerm
100 sg:journal.1112251 schema:issn 1355-008X
101 1559-0100
102 schema:name Endocrine
103 rdf:type schema:Periodical
104 sg:pub.10.1007/s12020-015-0575-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051714652
105 https://doi.org/10.1007/s12020-015-0575-0
106 rdf:type schema:CreativeWork
107 sg:pub.10.1038/s41574-018-0068-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105943493
108 https://doi.org/10.1038/s41574-018-0068-3
109 rdf:type schema:CreativeWork
110 https://doi.org/10.1001/jamasurg.2017.0461 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084514665
111 rdf:type schema:CreativeWork
112 https://doi.org/10.1016/j.bone.2014.10.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015212969
113 rdf:type schema:CreativeWork
114 https://doi.org/10.1016/j.ecl.2018.10.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110367878
115 rdf:type schema:CreativeWork
116 https://doi.org/10.1016/s2213-8587(18)30113-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1104252312
117 rdf:type schema:CreativeWork
118 https://doi.org/10.1016/s2213-8587(18)30306-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110228168
119 rdf:type schema:CreativeWork
120 https://doi.org/10.1089/thy.1998.8.737 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059318894
121 rdf:type schema:CreativeWork
122 https://doi.org/10.1089/thy.2014.0287 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059321919
123 rdf:type schema:CreativeWork
124 https://doi.org/10.1089/thy.2015.0020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007626247
125 rdf:type schema:CreativeWork
126 https://doi.org/10.1089/thy.2017.0177 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090618504
127 rdf:type schema:CreativeWork
128 https://doi.org/10.1089/thy.2017.0352 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103522639
129 rdf:type schema:CreativeWork
130 https://doi.org/10.1089/thy.2018.0186 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104548846
131 rdf:type schema:CreativeWork
132 https://doi.org/10.1093/pcmedi/pby001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103721372
133 rdf:type schema:CreativeWork
134 https://doi.org/10.1111/cen.12668 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041357370
135 rdf:type schema:CreativeWork
136 https://doi.org/10.1111/cen.13024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048581432
137 rdf:type schema:CreativeWork
138 https://doi.org/10.1111/cen.13158 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011770780
139 rdf:type schema:CreativeWork
140 https://doi.org/10.1210/jc.2010-0161 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064292019
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1210/jc.2012-1533 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064293516
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1210/jc.2012-3401 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064293913
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1210/jc.2013-3156 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064294609
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1210/jc.2016-2860 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011324995
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1210/jc.2018-02680 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112259219
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1515/jpem-2018-0075 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105227079
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1530/erc-15-0458 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000331339
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1530/erc-17-0453 schema:sameAs https://app.dimensions.ai/details/publication/pub.1093087164
157 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...